Clinical trial
Optimization of Cardiac Resynchronization Therapy and Its Effects in Patients With Type 2 Diabetes Mellitus: Automatic Optimization vs. Echocardiographic Guided Optimization.
NCT04547244 is registered in ClinicalTrials.gov with University of Campania Luigi Vanvitelli as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Optimization of Cardiac Resynchronization Therapy and Its Effects in Patients With Type 2 Diabetes Mellitus: Automatic Optimization vs. Echocardiographic Guided Optimization.
- Lead sponsor
- University of Campania Luigi Vanvitelli
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2015
- Completion date
- June 1, 2020
- Enrollment
- 200 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cardiac death, heart failure, heart failure with reduced ejection fraction